BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8204355)

  • 21. Invasive cutaneous malignant melanoma in Sweden, 1990-1999. A prospective, population-based study of survival and prognostic factors.
    Lindholm C; Andersson R; Dufmats M; Hansson J; Ingvar C; Möller T; Sjödin H; Stierner U; Wagenius G;
    Cancer; 2004 Nov; 101(9):2067-78. PubMed ID: 15372475
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gene expression profiling of primary cutaneous melanoma and clinical outcome.
    Winnepenninckx V; Lazar V; Michiels S; Dessen P; Stas M; Alonso SR; Avril MF; Ortiz Romero PL; Robert T; Balacescu O; Eggermont AM; Lenoir G; Sarasin A; Tursz T; van den Oord JJ; Spatz A;
    J Natl Cancer Inst; 2006 Apr; 98(7):472-82. PubMed ID: 16595783
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Age and gender are significant independent predictors of survival in primary cutaneous melanoma.
    Lasithiotakis K; Leiter U; Meier F; Eigentler T; Metzler G; Moehrle M; Breuninger H; Garbe C
    Cancer; 2008 Apr; 112(8):1795-804. PubMed ID: 18306371
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cutaneous melanoma in the Florentine area, Italy: incidence, survival and mortality between 1985 and 1994.
    Balzi D; Carli P; Giannotti B; Paci E; Buiatti E
    Eur J Cancer Prev; 2003 Feb; 12(1):43-8. PubMed ID: 12548109
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of prognostic factors and survival in cutaneous melanoma over 25 years: An analysis of the Central Malignant Melanoma Registry of the German Dermatological Society.
    Buettner PG; Leiter U; Eigentler TK; Garbe C
    Cancer; 2005 Feb; 103(3):616-24. PubMed ID: 15630700
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system.
    Balch CM; Soong SJ; Gershenwald JE; Thompson JF; Reintgen DS; Cascinelli N; Urist M; McMasters KM; Ross MI; Kirkwood JM; Atkins MB; Thompson JA; Coit DG; Byrd D; Desmond R; Zhang Y; Liu PY; Lyman GH; Morabito A
    J Clin Oncol; 2001 Aug; 19(16):3622-34. PubMed ID: 11504744
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Melanoma survival: sex does matter, but we do not know how.
    Crocetti E; Fancelli L; Manneschi G; Caldarella A; Pimpinelli N; Chiarugi A; Nardini P; Buzzoni C
    Eur J Cancer Prev; 2016 Sep; 25(5):404-9. PubMed ID: 26266895
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Survival and Surgical Outcomes for Pediatric Head and Neck Melanoma.
    Richards MK; Czechowicz J; Goldin AB; Gow KW; Doski J; Goldfarb M; Nuchtern J; Langer M; Beierle EA; Vasudevan S; Gupta D; Parikh SR
    JAMA Otolaryngol Head Neck Surg; 2017 Jan; 143(1):34-40. PubMed ID: 27607058
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic factors in cutaneous malignant melanoma in stage I. A clinical, morphological and multivariate analysis.
    Eldh J; Boeryd B; Peterson LE
    Scand J Plast Reconstr Surg; 1978; 12(3):243-55. PubMed ID: 741213
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Primary cutaneous melanoma. Identification of prognostic groups and estimation of individual prognosis for 5093 patients.
    Garbe C; Büttner P; Bertz J; Burg G; d'Hoedt B; Drepper H; Guggenmoos-Holzmann I; Lechner W; Lippold A; Orfanos CE
    Cancer; 1995 May; 75(10):2484-91. PubMed ID: 7736392
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of time to sentinel lymph node biopsy on cutaneous melanoma survival.
    Fortes C; Mastroeni S; Caggiati A; Passarelli F; Zappalà A; Capuano M; Bono R; Nudo M; Marino C; Michelozzi P
    Am J Surg; 2016 Nov; 212(5):935-940. PubMed ID: 27266393
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prediction of survival in patients with thin melanoma: results from a multi-institution study.
    Maurichi A; Miceli R; Camerini T; Mariani L; Patuzzo R; Ruggeri R; Gallino G; Tolomio E; Tragni G; Valeri B; Anichini A; Mortarini R; Moglia D; Pellacani G; Bassoli S; Longo C; Quaglino P; Pimpinelli N; Borgognoni L; Bergamaschi D; Harwood C; Zoras O; Santinami M
    J Clin Oncol; 2014 Aug; 32(23):2479-85. PubMed ID: 25002727
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sex differences in survival of cutaneous melanoma are age dependent: an analysis of 7338 patients.
    Mervic L; Leiter U; Meier F; Eigentler T; Forschner A; Metzler G; Bartenjev I; Büttner P; Garbe C
    Melanoma Res; 2011 Jun; 21(3):244-52. PubMed ID: 21540649
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Up-to-date survival estimates and historical trends of cutaneous malignant melanoma in the south-east of The Netherlands.
    de Vries E; Houterman S; Janssen-Heijnen ML; Nijsten T; van de Schans SA; Eggermont AM; Coebergh JW
    Ann Oncol; 2007 Jun; 18(6):1110-6. PubMed ID: 17434898
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A long-term analysis of 620 patients with malignant melanoma at a major referral center.
    Averbook BJ; Russo LJ; Mansour EG
    Surgery; 1998 Oct; 124(4):746-55; discussion 755-6. PubMed ID: 9780997
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Age as a key factor influencing metastasizing patterns and disease-specific survival after sentinel lymph node biopsy for cutaneous melanoma.
    Kretschmer L; Starz H; Thoms KM; Satzger I; Völker B; Jung K; Mitteldorf C; Bader C; Siedlecki K; Kapp A; Bertsch HP; Gutzmer R
    Int J Cancer; 2011 Sep; 129(6):1435-42. PubMed ID: 21064111
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thin cutaneous malignant melanomas (< or =1.5 mm): identification of risk factors indicative of progression.
    Massi D; Franchi A; Borgognoni L; Reali UM; Santucci M
    Cancer; 1999 Mar; 85(5):1067-76. PubMed ID: 10091790
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sentinel lymph node biopsy in patients with thin primary cutaneous melanoma.
    Murali R; Haydu LE; Quinn MJ; Saw RP; Shannon K; Spillane AJ; Stretch JR; Thompson JF; Scolyer RA
    Ann Surg; 2012 Jan; 255(1):128-33. PubMed ID: 21975320
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary cutaneous melanoma. Optimized cutoff points of tumor thickness and importance of Clark's level for prognostic classification.
    Büttner P; Garbe C; Bertz J; Burg G; d'Hoedt B; Drepper H; Guggenmoos-Holzmann I; Lechner W; Lippold A; Orfanos CE
    Cancer; 1995 May; 75(10):2499-2506. PubMed ID: 7736394
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic factors in young women with cutaneous melanoma.
    Burton AL; Egger ME; Quillo AR; Stromberg AJ; Hagendoorn L; Scoggins CR; Martin RC; McMasters KM; Callender GG
    Am J Surg; 2014 Jan; 207(1):102-8. PubMed ID: 24330977
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.